Life Sciences Single-Cell Genomics Instruments sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Life Sciences Single-Cell Genomics Instruments
1.1 - About Life Sciences Single-Cell Genomics Instruments sector
Companies in the Life Sciences Single-Cell Genomics Instruments category develop hardware and end‑to‑end workflows that isolate, partition, barcode, and prepare individual cells or nuclei for downstream sequencing and multi‑omics assays. Their systems deliver high‑throughput, reproducible single‑cell library preparation, minimizing manual variability while preserving sample integrity. Vendors provide instruments, reagents, consumables, and control software to streamline bench‑to‑sequencer processes for discovery research, translational programs, and genomics service operations.
Offerings typically include microfluidic droplet partitioning systems that co‑encapsulate cells with barcoded beads, nanowell or picowell capture platforms for plate‑based workflows, and automated instruments that perform reverse transcription and library construction for scRNA‑seq, scATAC‑seq, and multiome assays. Providers supply nuclei isolation modules, sample multiplexing/hashtagging chemistries, disposable chips and cartridges, and run management software with QC metrics to standardize protocols and ensure compatibility with leading NGS sequencers.
Primary customers include biopharma discovery teams, academic genomics core facilities, and clinical translational research labs. By adopting these platforms, buyers achieve higher cell throughput, lower cost per cell, and more consistent, reproducible data across studies. Workflows reduce hands‑on time and turnaround, increase success rates with low‑input samples, and integrate seamlessly with established NGS pipelines to accelerate target discovery and biomarker validation.
2. Buyers in the Life Sciences Single-Cell Genomics Instruments sector
2.1 Top strategic acquirers of Life Sciences Single-Cell Genomics Instruments companies
10x Genomics
- Description: Provider of life science technology platforms that combine single-cell and spatial genomics, offering Chromium, Visium and Xenium systems that enable transcriptomic profiling, multiomic studies and in-situ imaging for academic, translational and biopharmaceutical researchers across North America, Asia and Europe.
- Key Products:
- Chromium Single Cell Gene Expression: Generates 3' single-cell RNA-seq libraries with gel bead oligos containing Capture Sequence 1, enabling high-throughput transcriptome profiling of thousands of individual cells
- Single Cell Immune Profiling (5′ workflow): Uses 5′ chemistry compatible with barcoded antibodies and TCR/BCR sequencing to profile immune repertoires and gene expression from the same single cells
- Visium Spatial Gene Expression: Integrates spatial transcriptomics with immunofluorescence staining, allowing researchers to map gene expression within tissue sections while preserving spatial context
- Single Cell Gene Expression Flex: Flexible workflow supporting oligo-conjugated reagents like TotalSeq B and C to measure cell-surface proteins alongside gene expression for multiomic analyses.
- Company type: Publicly traded
- Employees: ●●●●●
- Enterprise value: $●●●●m
- Cash & ST investments: $●●●●m
- EV/Revenue (NTM): ●●.●x
- EV/EBITDA (NTM): ●●.●x
2.2 - Strategic buyer groups for Life Sciences Single-Cell Genomics Instruments sector
M&A buyer group 1: Nucleic Acid Sequencing
Neogen
- Type: N/A
- Employees: ●●●●●
- Description: Provider of food safety and quality assurance solutions for the pet-food sector, offering mycotoxin, pathogen, sanitation and allergen tests, environmental monitoring with microbiome analysis and analytics, plus verification tools, biosecurity, vector control and companion animal health products.
- Key Products:
- Environmental Monitoring Solutions: Provides Salmonella and ATP tests, analytic software, metagenomic microbiome analysis and biosecurity tools to strengthen facility-wide safety programs and enable rapid, data-driven contamination control
- Mycotoxin Testing Kits: Easy-to-use, fast and accurate kits that detect multiple mycotoxins, integrate seamlessly into safety programs and are supported by reference materials, proficiency testing and 24/7 assistance
- Vector Control Solutions: Broad portfolio of rodenticides and insecticides that follow a four-step prevention, identification, execution and monitoring program to eliminate disease-carrying pests in operations
- Companion Animal Health Products: Includes PanaKare Plus supplements for exocrine pancreatic insufficiency and RenaKare potassium supplementation, supporting specific nutritional needs of cats and dogs.
Buyer group 2: ████████ ████████
●● companiesBuyer group 3: ████████ ████████
●● companies3. Investors and private equity firms in Life Sciences Single-Cell Genomics Instruments sector
3.1 - Buyout funds in the Life Sciences Single-Cell Genomics Instruments sector
2.2 - Strategic buyer groups for Life Sciences Single-Cell Genomics Instruments sector
4 - Top valuation comps for Life Sciences Single-Cell Genomics Instruments companies
4.2 - Public trading comparable groups for Life Sciences Single-Cell Genomics Instruments sector
Valuation benchmark group 1: Clinical and Molecular Diagnostics Companies
Labcorp
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of comprehensive clinical laboratory and drug development services, harnessing science for human good with a wide range of diagnostic tests, specialty testing services, and research support globally.
- Key Products:
- Diagnostic Testing: Wide range of diagnostic tests for various conditions
- Specialty Testing: Advanced gene-based and esoteric testing
- Drug Development Services: Comprehensive services for drug development and clinical trials
- Health Screenings: Wellness, pediatric, COVID-19 antibody testing
- Labcorp OnDemand: At-home test kits and monitoring solutions